| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/06/2003 | WO2002010373A3 Apparatus and method for specific release of captured extension products |
| 02/06/2003 | WO2002010217A9 Endothelial cell expression patterns |
| 02/06/2003 | WO2002006499A3 Zmaxig1-specific polynucleotides and methods of use |
| 02/06/2003 | WO2002006331A3 14087, a serine protease molecule and uses therefor |
| 02/06/2003 | WO2002004668A3 Improved capture and detection of target nucleic acid in dipstick assays |
| 02/06/2003 | WO2002000919A3 Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring |
| 02/06/2003 | WO2002000883A3 Rescue of canine distemper virus from cdna |
| 02/06/2003 | WO2002000717A9 Novel co-stimulatory molecules |
| 02/06/2003 | WO2001096548A3 Human n-acetyltransferase family member and uses thereof |
| 02/06/2003 | WO2001096545A3 50090, a human hydratase and uses thereof |
| 02/06/2003 | WO2001096543A3 Method of increasing recovery of heterologous active enzymes produced in plants |
| 02/06/2003 | WO2001094617A3 Protein fragment complementation assay based on beta-lactamase |
| 02/06/2003 | WO2001094409A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 02/06/2003 | WO2001092500A9 Thermostable reverse transcriptases and uses thereof |
| 02/06/2003 | WO2001091801A3 Methods of transducing neural cells using lentivirus vectors |
| 02/06/2003 | WO2001091725A9 Biologically useful polyphosphates |
| 02/06/2003 | WO2001088199A3 Identification and modulationof of a t helper-1 and t helper-2 cells |
| 02/06/2003 | WO2001083769A9 Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis |
| 02/06/2003 | WO2001082973A3 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
| 02/06/2003 | WO2001079855A3 Method for quantification of akt protein expression |
| 02/06/2003 | WO2001079548A3 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction |
| 02/06/2003 | WO2001077330A3 G protein-coupled receptors |
| 02/06/2003 | WO2001075171B1 Methods, compositions and kits for the detection and monitoring of breast cancer |
| 02/06/2003 | WO2001073123A3 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 02/06/2003 | WO2001070765A9 Receptor-binding compounds and methods for identifying them |
| 02/06/2003 | WO2001064911A9 18232, a dual specificity phosphatase |
| 02/06/2003 | WO2001064874A9 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/06/2003 | WO2001048214A8 METHOD FOR PRODUCING 6-0-α-D-GLUCOPYRANOSYL-D-SORBITE |
| 02/06/2003 | WO2001047946A3 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 02/06/2003 | WO2001029251A8 Improved mutation analysis of the nf1 gene |
| 02/06/2003 | WO2001004335A8 Human-bovine chimeric respiratory syncytial virus vaccines |
| 02/06/2003 | US20030028927 Detecting genome vvariation in plants; obtain plant, extract nucleotide sequences, incubate with probe, monitor pattern, compare to control, detect adjsustment in hybridization pattern |
| 02/06/2003 | US20030028926 Recovering human nucleotide sequences from plant genome; obtain human clone from library, incubate with plant cells, transform, recover trangenic plants, propagate, detect snd recover library sequences in offspring genome |
| 02/06/2003 | US20030028925 Plant selectable marker and plant transformation method |
| 02/06/2003 | US20030028924 Nucleic acid molecule encoding the catalytic subunit of a protein phosphatase 2A that regulates flowering time in plants |
| 02/06/2003 | US20030028923 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants |
| 02/06/2003 | US20030028922 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 02/06/2003 | US20030028921 Polypeptide for use in generating disease resistant plants |
| 02/06/2003 | US20030028920 Antimicrobial polypeptides and their uses |
| 02/06/2003 | US20030028919 Transgenic trees having increased resistance to imidazolinone herbicides |
| 02/06/2003 | US20030028918 Method of imparting drought resistance to plants |
| 02/06/2003 | US20030028917 Reansgenic plant or bacteria for use in the generation of nonpolluting plastics and elastomers |
| 02/06/2003 | US20030028915 Nucleotide sequences coding enzymatic polypeptide for use in cleaving thioester bonds; for use in the generation of disease resistance in plants |
| 02/06/2003 | US20030028914 Analysis of genomic expression of genetically engineered plants; obtain plants, transform with heterologous gene, express genes, monitor exression, screen library for similarly recorded expression patterns |
| 02/06/2003 | US20030028913 Generation of antibody with preferential binding activity; obtain plant, transform with nucleotide sequences coding immunoglobulin, express nucleotide sequences, recover imunoglobulin |
| 02/06/2003 | US20030028911 Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| 02/06/2003 | US20030028910 Animal model for use in the diagnosis and treatment dietetics |
| 02/06/2003 | US20030028909 Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders |
| 02/06/2003 | US20030028908 Apparatus for microinjection of sample into amphibian oocytes |
| 02/06/2003 | US20030028906 Expression vector for use in the gene therapy |
| 02/06/2003 | US20030028905 Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms |
| 02/06/2003 | US20030028011 Screening effectiveness of viricides; obtain virally infected cells, expose to viricide, monitor viral gene expression, reduced viral expression indicates viricides |
| 02/06/2003 | US20030028010 Viral nucleotide sequene clone for use as tool in the treatment of viral diseases |
| 02/06/2003 | US20030028009 Polypeptide for use in the treatment of arthritis, psoriasis, cancer, inflammation, and diabetic retinopathy |
| 02/06/2003 | US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders |
| 02/06/2003 | US20030028006 Cytokine receptor common gamma chain like |
| 02/06/2003 | US20030028004 68730 and 69112, protein kinase molecules and uses therefor |
| 02/06/2003 | US20030028001 Expression vector for use as tool in the generation of insulin |
| 02/06/2003 | US20030028000 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |
| 02/06/2003 | US20030027999 143 human secreted proteins |
| 02/06/2003 | US20030027989 Nucleotide seq uences coding polypeptide for use in the diagnosis and treatment of cancer |
| 02/06/2003 | US20030027987 Novel polypeptide from Haemophilus paragallinarum and process for preparing the same |
| 02/06/2003 | US20030027985 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders |
| 02/06/2003 | US20030027981 Urokinase-type plasminogen activator receptor |
| 02/06/2003 | US20030027800 LPA receptor agonists and antagonists and methods of use |
| 02/06/2003 | US20030027784 Biologically tolerated low molecular weight polyethylenimines |
| 02/06/2003 | US20030027783 Introducing into the cell an RNA comprising a double stranded structure having nucleotide sequence which is substantially identical to part of target gene and which is derived from an endogenous template; verifying inhibition of expression |
| 02/06/2003 | US20030027782 Method for treating allergic lung disease |
| 02/06/2003 | US20030027781 Contacting mixture of nucleic acid sequences with blood brain barrier or CSF-blood barrier tissue; partitioning increased affinity nucleic acids from candidate mixture; amplifying increased to yield a mixture of nucleic acids |
| 02/06/2003 | US20030027779 Method for inducing DNA synthesis in neurons |
| 02/06/2003 | US20030027777 Methods for enhancing animal growth and cell proliferation by elimination of the cyclin-dependent kinase inhibitor function of p27Kip1 |
| 02/06/2003 | US20030027776 For detecting, therapy, prophylaxis and/or prognosing disorders related to the tissues where these cancer antigens are expressed |
| 02/06/2003 | US20030027774 For diagnosis and therapy of tuberculosis |
| 02/06/2003 | US20030027773 Protein-polycation conjugates |
| 02/06/2003 | US20030027765 Therapeutic peptides having a motif that binds specifically to non-acetylated H3 and H4 histones for cancer therapy |
| 02/06/2003 | US20030027764 Novel therapeutic and prophylactic agents and methods of using same |
| 02/06/2003 | US20030027754 As pharmaceuticals, diagnostics, biosensors and bioreactors |
| 02/06/2003 | US20030027752 Leucine-based motif and clostridial neurotoxins |
| 02/06/2003 | US20030027749 For use in therapy, and diagnostic assays |
| 02/06/2003 | US20030027746 Useful in the development of human therapeutics and diagnostic formulations |
| 02/06/2003 | US20030027743 Tripeptidylpeptidase inhibitors |
| 02/06/2003 | US20030027358 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 02/06/2003 | US20030027352 Multiple-site reaction apparatus and method |
| 02/06/2003 | US20030027340 Insertion sequence element derived from Ralstonia solanacearum |
| 02/06/2003 | US20030027337 Sequence-specific DNA recombination in eukaryotic cells |
| 02/06/2003 | US20030027336 Process of entrapping genetic materials in ultra-low size nanoparticles of inorganic compounds to form non-viral carriers |
| 02/06/2003 | US20030027335 Genome engineering by cell-permeable DNA site-specific recombinases |
| 02/06/2003 | US20030027334 Method for generating immortal dendritic cell lines |
| 02/06/2003 | US20030027322 Genration of herpesvirus amplicon particle for use in the treatment of cancer; obtain nucleotide sequences, incubate with expression vectors, ligate recover viral vector |
| 02/06/2003 | US20030027321 Recombinant RSV virus expression systems and vaccines |
| 02/06/2003 | US20030027320 Promoters for regulated gene expression |
| 02/06/2003 | US20030027319 Artificial antibody polypeptides |
| 02/06/2003 | US20030027317 Enzymatic polypeptide for use as tool in the treatment of viral diseases |
| 02/06/2003 | US20030027316 16051a and 16051b, novel human PDZ family members and uses thereof |
| 02/06/2003 | US20030027314 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 02/06/2003 | US20030027313 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 02/06/2003 | US20030027312 Isolated DNA sequence capable of serving as regulatory element in a chimeric gene which can be used for the transformation of plants |
| 02/06/2003 | US20030027309 Genes of purine biosynthesis from ashbya gossypii and the use thereof in microbial riboflavin synthesis |
| 02/06/2003 | US20030027303 Nucleotide sequences coding enzyme inhibitors for use in biological pest control |